SynthesisBlood cancer journal2025

Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma.

Lawrence Cheng Kiat Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.